LLY
Price
$770.31
Change
+$5.60 (+0.73%)
Updated
Sep 17, 12:30 PM (EDT)
Capitalization
685.53B
43 days until earnings call
PFE
Price
$24.15
Change
+$0.25 (+1.05%)
Updated
Sep 17, 03:32 PM (EDT)
Capitalization
135.88B
48 days until earnings call
Interact to see
Advertisement

LLY vs PFE

Header iconLLY vs PFE Comparison
Open Charts LLY vs PFEBanner chart's image
Eli Lilly & Co
Price$770.31
Change+$5.60 (+0.73%)
Volume$3.76K
Capitalization685.53B
Pfizer
Price$24.15
Change+$0.25 (+1.05%)
Volume$35.18K
Capitalization135.88B
LLY vs PFE Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LLY vs. PFE commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LLY is a Buy and PFE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 17, 2025
Stock price -- (LLY: $764.71 vs. PFE: $23.90)
Brand notoriety: LLY and PFE are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: LLY: 82% vs. PFE: 133%
Market capitalization -- LLY: $685.53B vs. PFE: $135.88B
LLY [@Pharmaceuticals: Major] is valued at $685.53B. PFE’s [@Pharmaceuticals: Major] market capitalization is $135.88B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $685.53B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $88.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LLY’s FA Score shows that 2 FA rating(s) are green whilePFE’s FA Score has 1 green FA rating(s).

  • LLY’s FA Score: 2 green, 3 red.
  • PFE’s FA Score: 1 green, 4 red.
According to our system of comparison, LLY is a better buy in the long-term than PFE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LLY’s TA Score shows that 7 TA indicator(s) are bullish while PFE’s TA Score has 4 bullish TA indicator(s).

  • LLY’s TA Score: 7 bullish, 2 bearish.
  • PFE’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, LLY is a better buy in the short-term than PFE.

Price Growth

LLY (@Pharmaceuticals: Major) experienced а +1.88% price change this week, while PFE (@Pharmaceuticals: Major) price change was -3.28% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.35%. For the same industry, the average monthly price growth was +0.70%, and the average quarterly price growth was +12.03%.

Reported Earning Dates

LLY is expected to report earnings on Oct 30, 2025.

PFE is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.35% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LLY($686B) has a higher market cap than PFE($136B). LLY has higher P/E ratio than PFE: LLY (49.98) vs PFE (12.65). LLY YTD gains are higher at: -0.352 vs. PFE (-5.067). PFE (20.2B) and LLY (19.7B) have comparable annual earnings (EBITDA) . PFE has more cash in the bank: 13.2B vs. LLY (3.55B). LLY has less debt than PFE: LLY (39.9B) vs PFE (60.9B). PFE has higher revenues than LLY: PFE (63.8B) vs LLY (53.3B).
LLYPFELLY / PFE
Capitalization686B136B504%
EBITDA19.7B20.2B98%
Gain YTD-0.352-5.0677%
P/E Ratio49.9812.65395%
Revenue53.3B63.8B84%
Total Cash3.55B13.2B27%
Total Debt39.9B60.9B66%
FUNDAMENTALS RATINGS
LLY vs PFE: Fundamental Ratings
LLY
PFE
OUTLOOK RATING
1..100
2172
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
24100
SMR RATING
1..100
1462
PRICE GROWTH RATING
1..100
6061
P/E GROWTH RATING
1..100
9698
SEASONALITY SCORE
1..100
4650

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PFE's Valuation (4) in the Pharmaceuticals Major industry is significantly better than the same rating for LLY (77). This means that PFE’s stock grew significantly faster than LLY’s over the last 12 months.

LLY's Profit vs Risk Rating (24) in the Pharmaceuticals Major industry is significantly better than the same rating for PFE (100). This means that LLY’s stock grew significantly faster than PFE’s over the last 12 months.

LLY's SMR Rating (14) in the Pharmaceuticals Major industry is somewhat better than the same rating for PFE (62). This means that LLY’s stock grew somewhat faster than PFE’s over the last 12 months.

LLY's Price Growth Rating (60) in the Pharmaceuticals Major industry is in the same range as PFE (61). This means that LLY’s stock grew similarly to PFE’s over the last 12 months.

LLY's P/E Growth Rating (96) in the Pharmaceuticals Major industry is in the same range as PFE (98). This means that LLY’s stock grew similarly to PFE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LLYPFE
RSI
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 2 days ago
53%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
44%
Bullish Trend 2 days ago
56%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
65%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
50%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
58%
Advances
ODDS (%)
Bullish Trend 7 days ago
68%
Bullish Trend 16 days ago
57%
Declines
ODDS (%)
Bearish Trend 3 days ago
53%
Bearish Trend 14 days ago
59%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
52%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
52%
View a ticker or compare two or three
Interact to see
Advertisement
LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ABXB19.950.12
+0.60%
Abacus Flexible Bond Leaders ETF
FYT56.560.08
+0.13%
First Trust Small Cap Val AlphaDEX® ETF
VGM9.99N/A
+0.05%
Invesco Trust Investment Grade Municipals
MEXX22.45-0.03
-0.13%
Direxion Dly MSCI Mexico Bull 3X ShsETF
PAVE46.48-0.26
-0.56%
Global X US Infrastructure Dev ETF

LLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with AZN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
+2.21%
AZN - LLY
40%
Loosely correlated
-0.63%
OGN - LLY
34%
Loosely correlated
-0.38%
MRK - LLY
34%
Loosely correlated
+0.09%
PFE - LLY
30%
Poorly correlated
-0.29%
NVS - LLY
29%
Poorly correlated
-0.43%
More